Business Investment Opportunities

- A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.

- We developed a prototype around three years back for a trial run and successfully launched the commercial version in November last year. - As of March this year, within a span of just 5 months, we have acquired over 25,000 registered users, with 16,000+ users regularly engaging. - Our business model operates on a freemium basis, offering a free trial period initially. A premium subscription is required to access the enhanced features, such as Chat. 'Profile boosts' and 'Pay-Per-Use vouchers' are our secondary revenue streams. - Notably, some users have proactively transitioned to premium accounts without solicitation. This has led to our first source of revenue and it started this year. - Our user acquisition strategy primarily involves social media advertisements and promotions to effectively target our desired audience. - Our subscription prices range from INR 999 for one month, INR 1,599 for 3 months, and INR 2,599 for six months. - We also allow reel videos to be uploaded by users on our platform, which is quite different from the picture only concept used by our competitors. - The app was built in-house, and our team consists of 1 UX developer, 2 Flutter developers, 2 full stack developers, 1 digital marketer, & 1 customer relations professional.

- Business primarily involved in the retail and distribution of fitness equipment, targeting both business-to-business (B2B) and business-to-consumer (B2C) segments. - Providing cardio and strength equipment, as well as fitness accessories. - The business is originally based in Mauritius but has secured exclusive distribution rights in Kenya for internationally recognized brands in the fitness industry. - Primarily imports products from China, leveraging the benefits of cost-effective manufacturing and supply chain resources in the region. - The market for the B2B business includes gyms and fitness centers, and B2C is through its physical store and online website. - Currently generating an annual turnover of MUR >20 million. - The owner is currently based in Mauritius and planning to start the business operations in Nairobi, Kenya.

- We have online shops for B2B & B2C customers in the following countries- Italy, Denmark, Netherlands, Germany, Austria, Estonia, Slovenia, and Sweden. - We have important brand contracts for distributing their products in the EU. - Our company has a proven track record of distributing high-quality products from around the world. - Have partnership with over 4 companies to distribute the beverages.

- The company is a fully integrated Ready to Cook, D2C startup delivering premium imported ingredients in the form of DIY kits to simplify cooking Global recipes right at your home. Key Business Highlights: * Revenue has grown exponentially 24X in the last 2 Months. * 70%+ Gross Margin. * 8,000+ kits delivered, pan India. * First mover in the segment and space. * Completely asset lite model. * Have over 9 SKUs currently expanding to 2 new SKUs every month. * Non-perishable ingredients with kits ranging with shelflife from 6 months to 1 Year.

- SaaS platform to create e-commerce and digital business solutions instantly on Cloud. - The project is early stage and currently catering to 7+ clients who are on-boarded and started on early access to the platform. - We generate revenue by charging subscription fees (depending on SKUs). - Discovery focuses on providing a general business digital solution for small and medium businesses. - Will help entrepreneurs create digital solutions for business and e-commerce independently and quickly. It helps them to reduce the Capex and Opex and also helps them to reduce the technology dependencies. - The company was established 3 years ago but the revenue generation started recently. - The company is expected to 20x growth and the company's business plan and market have the potential to achieve 50M USD in 4-5 years. - We also have around 50 employees who work on the development side of our products, and we have a few freelancers who help with marketing as well.

- Business is revolutionizing the management of chronic and neuropathic pain in India with a focus on safety and efficacy. - Our licensed healthcare company is pioneering the country's first range of GMP-compliant, lab-certified, ayurvedic cannabinoid formulations designed to provide patients with a natural alternative to traditional pain medications. - First mover advantage: First to bring cannabinoid based pain management solutions into mainstream healthcare and retail in India. - Onco Range: Launched India's first and only Onco-focused range of CBD formulations addressing big problem areas in cancer care. - Endorsement from the medical community: Extensive inroads into the medical community with KOL's prescribing and endorsing our medications. - Backed by clinical trials: 1st Indian company to conduct clinical trials and bring CBD-based pain management products into mainstream healthcare and retail. - Extensive distribution: Access to extensive distribution through partnerships with the largest healthcare and big box companies such as Apollo, Guardian, Genisan Healthcare, Max Group, Spencer’s Retail, and Nature Basket. - Traction: Since last year, 9X growth in Offline sales and 3X growth in sales. - Marquee investors onboarded from Apollo Hospital, Panthera Peak Ventures, IIFL Finance,  Mahindra First. - The business has all the required licenses and certifications.